Unknown

Dataset Information

0

Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein-RNA Interaction of LIN28 and Let-7.


ABSTRACT: Modulation of protein-RNA interaction (PRI) using small molecules is a promising strategy to develop therapeutics. LIN28 is an RNA-binding protein that blocks the maturation of the tumor suppressor let-7 microRNAs. Herein, we performed a fluorescence polarization-based screening and identified trisubstituted pyrrolinones as small-molecule inhibitors disrupting the LIN28-let-7 interaction. The most potent compound C902 showed dose-dependent inhibition in an EMSA validation assay, enhanced thermal stability of the cold shock domain of LIN28, and increased mature let-7 levels in JAR cells. The structure-activity relationship study revealed key structural features contributing to either PRI inhibition or stabilization of protein-protein interaction (PPI). The pyrrolinones identified in this study not only represent a new class of LIN28-binding molecules that diversify the limited available LIN28 inhibitors but also represent the first examples of small molecules that showed substituent-dependent PRI inhibitory and PPI activating activities.

SUBMITTER: Borgelt L 

PROVIDER: S-EPMC8201479 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein-RNA Interaction of LIN28 and <i>Let-7</i>.

Borgelt Lydia L   Li Fu F   Hommen Pascal P   Lampe Philipp P   Hwang Jimin J   Goebel Georg L GL   Sievers Sonja S   Wu Peng P  

ACS medicinal chemistry letters 20210301 6


Modulation of protein-RNA interaction (PRI) using small molecules is a promising strategy to develop therapeutics. LIN28 is an RNA-binding protein that blocks the maturation of the tumor suppressor <i>let-7</i> microRNAs. Herein, we performed a fluorescence polarization-based screening and identified trisubstituted pyrrolinones as small-molecule inhibitors disrupting the LIN28-<i>let-7</i> interaction. The most potent compound C902 showed dose-dependent inhibition in an EMSA validation assay, en  ...[more]

Similar Datasets

| S-EPMC6004563 | biostudies-literature
| S-SCDT-10_1038-S44321-024-00085-3 | biostudies-other
| S-EPMC10160951 | biostudies-literature
| S-EPMC7179467 | biostudies-literature
| S-EPMC5823691 | biostudies-literature
| S-EPMC5734307 | biostudies-literature
| S-EPMC4159589 | biostudies-literature
| S-EPMC5734307 | biostudies-literature
| S-EPMC5180416 | biostudies-literature
| S-EPMC10304769 | biostudies-literature